These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33676105)

  • 1. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.
    Puzyrenko A; Felix JC; Sun Y; Rui H; Sheinin Y
    Pathol Res Pract; 2021 Apr; 220():153380. PubMed ID: 33676105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis.
    Puzyrenko A; Felix JC; Ledeboer NA; Sun Y; Rui H; Sheinin Y
    Pathology; 2022 Jun; 54(4):404-408. PubMed ID: 34836647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of highly cytotoxic CD8
    Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
    Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of antigen-presenting cells in lung of postmortem SARS-CoV-2 cases.
    Rasheed TK
    Cell Mol Biol (Noisy-le-grand); 2024 Sep; 70(8):50-56. PubMed ID: 39262263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of CCR4 in activated CD8
    Spoerl S; Kremer AN; Aigner M; Eisenhauer N; Koch P; Meretuk L; Löffler P; Tenbusch M; Maier C; Überla K; Heinzerling L; Frey B; Lutzny-Geier G; Winkler TH; Krönke G; Vetter M; Bruns H; Neurath MF; Mackensen A; Kremer AE; Völkl S
    Eur J Immunol; 2021 Jun; 51(6):1436-1448. PubMed ID: 33784417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell dysregulation in COVID-19.
    Kalfaoglu B; Almeida-Santos J; Tye CA; Satou Y; Ono M
    Biochem Biophys Res Commun; 2021 Jan; 538():204-210. PubMed ID: 33220925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
    Georg P; Astaburuaga-García R; Bonaguro L; Brumhard S; Michalick L; Lippert LJ; Kostevc T; Gäbel C; Schneider M; Streitz M; Demichev V; Gemünd I; Barone M; Tober-Lau P; Helbig ET; Hillus D; Petrov L; Stein J; Dey HP; Paclik D; Iwert C; Mülleder M; Aulakh SK; Djudjaj S; Bülow RD; Mei HE; Schulz AR; Thiel A; Hippenstiel S; Saliba AE; Eils R; Lehmann I; Mall MA; Stricker S; Röhmel J; Corman VM; Beule D; Wyler E; Landthaler M; Obermayer B; von Stillfried S; Boor P; Demir M; Wesselmann H; Suttorp N; Uhrig A; Müller-Redetzky H; Nattermann J; Kuebler WM; Meisel C; Ralser M; Schultze JL; Aschenbrenner AC; Thibeault C; Kurth F; Sander LE; Blüthgen N; Sawitzki B;
    Cell; 2022 Feb; 185(3):493-512.e25. PubMed ID: 35032429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Frequencies of Functional Virus-Specific CD4
    Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
    Front Immunol; 2021; 12():748881. PubMed ID: 34858405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
    Kared H; Redd AD; Bloch EM; Bonny TS; Sumatoh H; Kairi F; Carbajo D; Abel B; Newell EW; Bettinotti MP; Benner SE; Patel EU; Littlefield K; Laeyendecker O; Shoham S; Sullivan D; Casadevall A; Pekosz A; Nardin A; Fehlings M; Tobian AA; Quinn TC
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33427749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.
    Loske J; Röhmel J; Lukassen S; Stricker S; Magalhães VG; Liebig J; Chua RL; Thürmann L; Messingschlager M; Seegebarth A; Timmermann B; Klages S; Ralser M; Sawitzki B; Sander LE; Corman VM; Conrad C; Laudi S; Binder M; Trump S; Eils R; Mall MA; Lehmann I
    Nat Biotechnol; 2022 Mar; 40(3):319-324. PubMed ID: 34408314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19.
    Mellinghoff SC; Vanshylla K; Dahlke C; Addo MM; Cornely OA; Klein F; Persigehl T; Rybniker J; Gruell H; Bröckelmann PJ
    Front Immunol; 2021; 12():798276. PubMed ID: 34987520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
    Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong SARS-CoV-2 N-Specific CD8
    Ferrantelli F; Chiozzini C; Manfredi F; Leone P; Spada M; Di Virgilio A; Giovannelli A; Sanchez M; Cara A; Michelini Z; Federico M
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.